CE Mark Granted to Cynosure Lutronic’s Mosaic 3D

Cynosure Lutronic has received CE Mark approval for the Mosaic 3D, a non-ablative fractional laser that delivers more energy and covers more areas while ensuring safety with minimal discomfort and downtime for patients.

“Mosaic 3D introduces a new level of control and adaptability in fractional resurfacing,” commented aesthetic physician Guy Erlich, M.D., an international trainer for Cynosure Lutronic. “In both clinical practice and ongoing studies, we are seeing excellent tissue response and a high degree of treatment flexibility, making it a powerful platform for advanced resurfacing indications.”

Mosaic 3D features include:

• 3D Controlled Chaos Technology: Optimizing the distribution and depth of multi-depth microbeams, 3D CCT helps reduce the risk of bulk thermal heating, allowing for an increase in treatment coagulation volume per stamp, without sacrificing safety.
• Integrated cooling system: Enables providers to safely and effectively address sensitive treatment areas around the eyes and mouth. Integrated air-cooling flows through the handpiece and onto the unique cold-compression sapphire tips. This synergy reduces pain, erythema, and edema, and is to enhance treatment efficacy, safety, and comfort.
• Versatility: Creates a new canvas on the skin by enhancing neocollagenesis and neoelastinogenesis in the mid-dermis, leading to revitalised and brightened skin.* With its upgraded metal rollers and new sapphire tips, MOSAIC 3D rolling and stamping applications in one laser platform. Easy, air-cooled rolling enables efficient coverage and exceptional efficacy, while 3D CCT stamping in challenging areas.

Mosaic 3D is currently being used in clinical practice and investigator-led studies by internationally recognized experts, including Dr. Erlich (Israel), Professor Merete Haedersdal (Denmark), and Dr. Tatiana Kuznechenkova (United Arab Emirates).

“Our clinical study with Mosaic 3D on how imaging analyses have allowed us to gain a better understanding of laser-tissue interactions with Mosaic 3D to optimize treatment protocols for our patients has generated very promising results,” Haedersdal said. “The data is currently being finalized for publication…”

“After several weeks of clinical use, Mosaic 3D has delivered promising and very encouraging results,” Dr. Kuznechenkova added. “Its precision and adaptability allow for highly customized treatments, which is reflected in both patient satisfaction and clinical outcomes.”

With more than 30 years of combined innovation and leadership in energy-based devices, Cynosure Lutronic enables dermatologists, plastic surgeons, and aesthetic practitioners worldwide to deliver non-invasive and minimally invasive treatments. The company has built a comprehensive portfolio across skin resurfacing, revitalization, hair removal, vascular treatments, skin toning, and body contouring. Cynosure Lutronic operates through direct sales in the United States, Canada, Germany, Spain, the United Kingdom, Australia, China, Japan, and Korea, and through distributors in approximately 130 countries worldwide.